PELOTONIA
Columbuus, OH, US
•
501(c)3
•
EIN
82-4997087
•
•
Single Organization Support
Regional Funder
Columbuus, OH, US
•
501(c)3
•
EIN
82-4997087
•
•
Single Organization Support
Regional Funder
Programs
Program 1 [2020]
PELOTONIA SUPPORTS HIGH-RISK, HIGH-REWARD CANCER RESEARCH INITIATIVES AT THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER ARTHUR G. JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITUTE. THE FUNDS RAISED SUPPORT PROJECTS THAT ADDRESS MANY AREAS OF CANCER RESEARCH, INCLUDING PREVENTION, DIAGNOSIS, TREATMENT, PSYCHOSOCIAL ISSUES, ACCELERATED DRUG DEVELOPMENT, AND LARGE INITIATIVES THAT HELP CHANGE THE LANDSCAPE OF CANCER CARE AND OFFER HELP AND HOPE TO PATIENTS AND FAMILIES FROM AROUND THE WORLD. PELOTONIA FUNDS ARE NOT RESTRICTED TO SPECIFIC CANCER TYPES, ALLOWING US TO INVEST IN INNOVATION ACROSS ALL CANCERS, FUNDING THE HIGHEST PRIORITY AND QUALITY RESEARCH ANNUALLY. IN FY 2020, PELOTONIA NEWLY AWARDED 42 FELLOWSHIP PROGRAM AWARDS TO EMPOWER YOUNG INNOVATORS ACROSS ACADEMIC FIELDS AND DISCIPLINES TO PURSUE A CAREER IN CANCER RESEARCH; 9 IDEA GRANTS TO ENABLE SCIENTISTS TO PURSUE NEW APPROACHES TO CANCER RESEARCH, AND 1 STATEWIDE INITIATIVE GRANT FOCUSED ONREDUCING THE HIGH BREAST CANCER MORTALITY AMONG AFRICAN AMERICAN WOMEN IN OHIO. PELOTONIA CONTINUED ONGOING PROGRAMMATIC INVESTMENTS IN THE PELOTONIA INSTITUTE FOR IMMUNO-ONCOLOGY (PIIO), A COMPREHENSIVE BENCH-TO-BEDSIDE RESEARCH INITIATIVE FOCUSED ON HARNESSING THE IMMUNE SYSTEM TO FIGHT CANCER; RECRUITMENT AND RETENTION OF TOP CANCER SCIENTISTS; SOPHISTICATED EQUIPMENT REQUIRED FOR CUTTING-EDGE CANCER DISCOVERIES; STRATEGIC RESEARCH INVESTMENTS IN THE DRUG DEVELOPMENT INSTITUTE, DIGITAL PATHOLOGY AND TOTAL CANCER CARE PROTOCOL PROGRAMS AT THE OSUCCC JAMES AND MORE.GeographiesNot indicatedDatesJan 1, 2020 – Dec 31, 2020Source990No causes providedNo populations provided–$16.3MPelotonia Cancer Research Initiatives
PELOTONIA SUPPORTS HIGH-RISK, HIGH-REWARD CANCER RESEARCH INITIATIVES AT THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER ARTHUR G. JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITUTE. THE FUNDS RAISED SUPPORT PROJECTS THAT ADDRESS MANY AREAS OF CANCER RESEARCH, INCLUDING PREVENTION, DIAGNOSIS, TREATMENT, PSYCHOSOCIAL ISSUES, ACCELERATED DRUG DEVELOPMENT, AND LARGE INITIATIVES THAT HELP CHANGE THE LANDSCAPE OF CANCER CARE AND OFFER HELP AND HOPE TO PATIENTS AND FAMILIES FROM AROUND THE WORLD. PELOTONIA FUNDS ARE NOT RESTRICTED TO SPECIFIC CANCER TYPES, ALLOWING US TO INVEST IN INNOVATION ACROSS ALL CANCERS, FUNDING THE HIGHEST PRIORITY AND QUALITY RESEARCH ANNUALLY. SEE SCHEDULE O.IN FY 2023, PELOTONIA AWARDED FELLOWSHIP PROGRAM AWARDS TO EMPOWER YOUNG INNOVATORS ACROSS ACADEMIC FIELDS AND DISCIPLINES TO PURSUE A CAREER IN CANCER RESEARCH; IDEA GRANTS TO ENABLE SCIENTISTS TO PURSUE NEW APPROACHES TO CANCER RESEARCH; AND STATEWIDE INITIATIVE GRANTS FOCUSED ON ASSESSING SURVIVAL AND QUALITY OF LIFE FOR ADVANCED STAGE LUNG CANCER, SMOKING CESSATION, AND REDUCING THE HIGH BREAST CANCER MORTALITY AMONG AFRICAN AMERICAN WOMEN IN OHIO. PELOTONIA CONTINUED ONGOING PROGRAMMATIC INVESTMENTS IN THE PELOTONIA INSTITUTE FOR IMMUNO-ONCOLOGY (PIIO); A COMPREHENSIVE BENCH-TO-BEDSIDE RESEARCH INITIATIVE FOCUSED ON HARNESSING THE IMMUNE SYSTEM TO FIGHT CANCER; RECRUITMENT AND RETENTION OF TOP CANCER SCIENTISTS; SOPHISTICATED EQUIPMENT REQUIRED FOR CUTTING-EDGE CANCER DISCOVERIES; STRATEGIC RESEARCH INVESTMENTS IN THE DRUG DEVELOPMENT INSTITUTE; DIGITAL PATHOLOGY; AND TOTAL CANCER CARE PROTOCOL PROGRAMS AT THE OSUCCC - JAMES.GeographiesNot indicatedDatesJan 1, 2023 – Dec 31, 2023Source990No causes providedNo populations provided–$27.8MVictoria's Secret Global Fund for Women's Cancers
IN 2022, PELOTONIA, IN COLLABORATION WITH VICTORIA'S SECRET AND THE AMERICAN ASSOCIATION OF CANCER RESEARCH, ESTABLISHED "THE VICTORIA'S SECRET GLOBAL FUND FOR WOMEN'S CANCERS," TO SUPPORT RESEARCH AIMED AT PREVENTING, DETECTING, TREATING AND SUPPORTING THE SURVIVORSHIP OF WOMEN WITH CANCER AND INVESTING IN THE NEXT GENERATION OF WOMEN SCIENTISTS WHO REPRESENT THE DIVERSE POPULATION THEY SERVE.GeographiesNot indicatedDatesJan 1, 2023 – Dec 31, 2023Source990No causes providedNo populations provided–$2.6M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)